Basic Information
| RNALocate ID: | RLID:01001727 |
| RNA Symbol: | hsa-miR-23b-3p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-23b |
| RNA ID: | miRBase:MIMAT0000418 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 27396686 |
| Tissue/Cell Line: | Myotube |
| Method: | qRT-PCR |
| Description: | Interestingly, miRNA loaded AGO2 and AGO3 proteins has been recently found in mitochondria [19] (Fig. 2), however, the main AGO binding partner-GW182- was absent [185], indicating that the common cytoplasmic RNA-silencing machinery does not operate in mitochondria. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001725 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001726 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001728 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001729 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001730 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001731 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001732 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11001669 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001670 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001671 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001672 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001673 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11001674 | Exosome | Breast milk | 22211110 |
| RLID:11001675 | Exosome | Brain tissue | 23382797 |
| RLID:11001676 | Exosome | Plasma | 23663360 |
| RLID:11001677 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001678 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001679 | Microvesicle | Plasma | 23077538 |
| RLID:11001680 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000071 | Exosome | Endothelial cells|Epithelial cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000346 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-23b-3p | Diffuse large b cell lymphoma | MNDR-E-MI-32119 |
| MNDR | hsa-miR-23b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-32120 |
| MNDR | hsa-miR-23b-3p | Oral squamous cell carcinoma | MNDR-E-MI-32121 |
| MNDR | hsa-miR-23b-3p | Medulloblastoma | MNDR-E-MI-32122 |
| MNDR | hsa-miR-23b-3p | B cell lymphoma of malt type | MNDR-E-MI-32123 |
| MNDR | hsa-miR-23b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-32124 |
| MNDR | hsa-miR-23b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-32125 |
| MNDR | hsa-miR-23b-3p | Lymphoma | MNDR-E-MI-32126 |
| MNDR | hsa-miR-23b-3p | Non-hodgkin lymphoma | MNDR-E-MI-32127 |
| MNDR | hsa-miR-23b-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-32128 |
| MNDR | hsa-miR-23b-3p | Dermatomyositis | MNDR-E-MI-32129 |
| MNDR | hsa-miR-23b-3p | Prostate cancer | MNDR-E-MI-32130 |
| MNDR | hsa-miR-23b-3p | Gastric cancer | MNDR-E-MI-32131 |
| MNDR | hsa-miR-23b-3p | Gastric lymphoma | MNDR-E-MI-32132 |
| MNDR | hsa-miR-23b-3p | Alzheimer disease | MNDR-E-MI-32133 |
| MNDR | hsa-miR-23b-3p | Intracranial aneurysm | MNDR-E-MI-32134 |
| MNDR | hsa-miR-23b-3p | Bladder cancer | MNDR-E-MI-32135 |
| MNDR | hsa-miR-23b-3p | Esophageal carcinoma | MNDR-E-MI-32136 |
| MNDR | hsa-miR-23b-3p | Dysautonomia familial | MNDR-E-MI-32137 |
| MNDR | hsa-miR-23b-3p | Myotonic dystrophy | MNDR-E-MI-32138 |
| MNDR | hsa-miR-23b-3p | Seizures | MNDR-E-MI-32139 |
| MNDR | hsa-miR-23b-3p | Huntington disease | MNDR-E-MI-32140 |
| MNDR | hsa-miR-23b-3p | Cardiovascular disease | MNDR-E-MI-32141 |
| MNDR | hsa-miR-23b-3p | Carotid stenosis | MNDR-E-MI-32142 |
| MNDR | hsa-miR-23b-3p | Brain cancer | MNDR-E-MI-32143 |
| MNDR | hsa-miR-23b-3p | Uterine fibroid | MNDR-E-MI-32144 |
| MNDR | hsa-miR-23b-3p | Lung cancer | MNDR-E-MI-32145 |
| MNDR | hsa-miR-23b-3p | Down syndrome | MNDR-E-MI-32146 |
| MNDR | hsa-miR-23b-3p | Parkinson disease | MNDR-E-MI-32147 |
| MNDR | hsa-miR-23b-3p | Breast cancer | MNDR-E-MI-32148 |
| MNDR | hsa-miR-23b-3p | Thyroid cancer | MNDR-E-MI-32149 |
| MNDR | hsa-miR-23b-3p | Pituitary neoplasms | MNDR-E-MI-32150 |
| MNDR | hsa-miR-23b-3p | Pancreatic cancer | MNDR-E-MI-32151 |
| MNDR | hsa-miR-23b-3p | Melanoma | MNDR-E-MI-32152 |
| MNDR | hsa-miR-23b-3p | Nephroblastoma | MNDR-E-MI-32153 |
| MNDR | hsa-miR-23b-3p | Colon cancer | MNDR-E-MI-32154 |
| MNDR | hsa-miR-23b-3p | Ischemic attack transient | MNDR-E-MI-32155 |
| MNDR | hsa-miR-23b-3p | Colon adenocarcinoma | MNDR-E-MI-32156 |
| MNDR | hsa-miR-23b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-32157 |
| MNDR | hsa-miR-23b-3p | Familial ovarian cancer | MNDR-E-MI-32158 |
| MNDR | hsa-miR-23b-3p | Prostate adenocarcinoma | MNDR-E-MI-32159 |
| MNDR | hsa-miR-23b-3p | Renal cancer | MNDR-E-MI-32160 |
| MNDR | hsa-miR-23b-3p | Carcinoma ductal breast | MNDR-E-MI-32161 |
| MNDR | hsa-miR-23b-3p | Glioblastoma | MNDR-E-MI-32162 |
| MNDR | hsa-miR-23b-3p | Glioma | MNDR-E-MI-32163 |
| MNDR | hsa-miR-23b-3p | Chordoma | MNDR-E-MI-32164 |
| MNDR | hsa-miR-23b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-32165 |
| MNDR | hsa-miR-23b-3p | Temporal lobe epilepsy | MNDR-E-MI-32166 |
| MNDR | hsa-miR-23b-3p | Osteosarcoma | MNDR-E-MI-32167 |
| MNDR | hsa-miR-23b-3p | Liposarcoma | MNDR-E-MI-32168 |
| MNDR | hsa-miR-23b-3p | Inclusion body myositis | MNDR-E-MI-32169 |
| MNDR | hsa-miR-23b-3p | Meningioma | MNDR-E-MI-32170 |
| MNDR | hsa-miR-23b-3p | Liver cancer | MNDR-E-MI-32171 |
| MNDR | hsa-miR-23b-3p | Uterine cancer | MNDR-E-MI-32172 |
| MNDR | hsa-miR-23b-3p | Cervical adenocarcinoma | MNDR-E-MI-32173 |
| MNDR | hsa-miR-23b-3p | Gastric adenocarcinoma | MNDR-E-MI-32174 |
| MNDR | hsa-miR-23b-3p | Cervical squamous cell carcinoma | MNDR-E-MI-32175 |
| MNDR | hsa-miR-23b-3p | Pituitary adenoma | MNDR-E-MI-32176 |
| MNDR | hsa-miR-23b-3p | Lung squamous cell carcinoma | MNDR-E-MI-32177 |
| MNDR | hsa-miR-23b-3p | Carcinoma lung non-small-cell | MNDR-E-MI-32178 |
| MNDR | hsa-miR-23b-3p | Lung adenocarcinoma | MNDR-E-MI-32179 |
| MNDR | hsa-miR-23b-3p | Thyroid carcinoma | MNDR-E-MI-32180 |
| MNDR | hsa-miR-23b-3p | Ovarian carcinoma | MNDR-E-MI-32181 |
| MNDR | hsa-miR-23b-3p | Bladder urothelial carcinoma | MNDR-E-MI-32182 |
| MNDR | hsa-miR-23b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-32183 |
| MNDR | hsa-miR-23b-3p | Cervical cancer | MNDR-E-MI-32184 |
| MNDR | hsa-miR-23b-3p | Carcinoma renal cell | MNDR-E-MI-32185 |
| MNDR | hsa-miR-23b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-32186 |
| MNDR | hsa-miR-23b-3p | Renal clear cell carcinoma | MNDR-E-MI-32187 |
| MNDR | hsa-miR-23b-3p | Cholangiocarcinoma | MNDR-E-MI-32188 |
| MNDR | hsa-miR-23b-3p | Esophageal cancer | MNDR-E-MI-32189 |
| MNDR | hsa-miR-23b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-32190 |
| MNDR | hsa-miR-23b-3p | T acute lymphoblastic leukemia | MNDR-E-MI-32191 |
| MNDR | hsa-miR-23b-3p | Acute t cell leukemia | MNDR-E-MI-32192 |
| MNDR | hsa-miR-23b-3p | Fibromyalgia | MNDR-E-MI-32193 |
| MNDR | hsa-miR-23b-3p | Adenoma | MNDR-E-MI-32194 |
| MNDR | hsa-miR-23b-3p | Breast invasive carcinoma | MNDR-E-MI-32195 |
| MNDR | hsa-miR-23b-3p | Hepatocellular carcinoma | MNDR-E-MI-32196 |
| MNDR | hsa-miR-23b-3p | Familiar ovarian carcinoma | MNDR-E-MI-32197 |
| MNDR | hsa-miR-23b-3p | B-cell lymphoma | MNDR-E-MI-32198 |
| MNDR | hsa-miR-23b-3p | Rheumatoid arthritis | MNDR-E-MI-32199 |
| MNDR | hsa-miR-23b-3p | Malignant pleural mesothelioma | MNDR-E-MI-32200 |
| MNDR | hsa-miR-23b-3p | Neuroblastoma | MNDR-E-MI-32201 |
| MNDR | hsa-miR-23b-3p | Hodgkin lymphoma | MNDR-E-MI-32202 |
| MNDR | hsa-miR-23b-3p | Ulcerative colitis | MNDR-E-MI-32203 |
| MNDR | hsa-miR-23b-3p | Neuromyelitis optica | MNDR-E-MI-32204 |
| MNDR | hsa-miR-23b-3p | Acute myeloid leukemia | MNDR-E-MI-32205 |
| MNDR | hsa-miR-23b-3p | Colorectal cancer | MNDR-E-MI-32206 |
| MNDR | hsa-miR-23b-3p | Multiple myeloma | MNDR-E-MI-32207 |
| MNDR | hsa-miR-23b-3p | Acute lymphocytic leukemia | MNDR-E-MI-32208 |
| MNDR | hsa-miR-23b-3p | Uterine cervical neoplasms | MNDR-E-MI-32209 |
| MNDR | hsa-miR-23b-3p | Diabetic nephropathies | MNDR-E-MI-32210 |
| MNDR | hsa-miR-23b-3p | Ependymoma | MNDR-E-MI-32211 |
| MNDR | hsa-miR-23b-3p | Cardiomegaly | MNDR-E-MI-32212 |
| MNDR | hsa-miR-23b-3p | Nasopharyngeal cancer | MNDR-E-MI-32213 |
| MNDR | hsa-miR-23b-3p | Prostatic neoplasms | MNDR-E-MI-32214 |
| MNDR | hsa-miR-23b-3p | Sleep deprivation | MNDR-E-MI-32215 |
| MNDR | hsa-miR-23b-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-32216 |
| MNDR | hsa-miR-23b-3p | Brain injury chronic | MNDR-E-MI-32217 |
| MNDR | hsa-miR-23b-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-32218 |
| MNDR | hsa-miR-23b-3p | Stroke lacunar | MNDR-E-MI-32219 |
| MNDR | hsa-miR-23b-3p | Low grade dysplastic nodule | MNDR-E-MI-32220 |
| MNDR | hsa-miR-23b-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-32221 |
| MNDR | hsa-miR-23b-3p | Tubulovillous adenoma | MNDR-E-MI-32222 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR2B | Homo sapiens | RR00039546 |
TOP